期刊文献+

原发性高血压发病机制及治疗探讨 被引量:22

The Pathogenesis and Treatment of Essential Hypertension
下载PDF
导出
摘要 目的:探讨原发性高血压的发病机制及治疗。方法:从人体为一统一的有机整体出发,从辨证的角度,通过对机体与损伤因子之间相互作用所发生的损伤效应及机体的去损伤调节的分析,探讨高血压病可能的发生机制。并以此为基础,将治疗高血压的药物按改善靶器官功能及调节神经内分泌因子进行分类,提出合理的治疗方案。结果:原发性高血压与内因的调控及外因的诱导密切相关。任何损伤因子的存在必将引起机体的去损伤效应而使效应器官达到新的平衡。由于个体的差异及损伤因子性质的不同,对损伤因子过于敏感及调节能力差的个体易于出现调节紊乱,在神经内分泌因子的参与下导致高血压的形成。因在高血压不同的阶段机体相应靶器官紊乱程度不同,故治疗方案视相应靶器官的功能状况而存在差异。结论:原发性高血压与基因表达的时间依从性及相关基因的诱导表达密切相关。高血压发病初期,应以改善靶器官自身功能的药物为主,辅以小剂量调节神经内分泌的药物为佳;对靶器官已损伤者,调节神经内分泌的药物为必需,联用改善靶器官功能的药物作为基础,利于靶器官结构及功能的恢复。 Objective:To investigate the pathogenesis and treatment of essential hypertension.Methods: Take from the human body as a unified whole,to analysis the damaging effect and the adjusting of removing damage from the body caused by the interactions between the body and damage factor from the dialectical angle to investigate the pathogenesis of essential hypertension.Based on these,to classify the drug treatment for hypertension according to improve target organ function and the adjustment nerve internal secretion factor,proposing the reasonable treatment plan.Results: Essential hypertension is closely related with internal controlled and external induced.Any damage factor existence will certainly to cause the effect of removing damage by the organism to enable the effect organ to achieve the new balance.For the difference of the individual and the damage factor,to be sensitive to damages factor and the low of the adjustment ability individual easy to have the adjustment disorder,causes hypertension in under the nerve internal secretion factor participation the formation.Because of in different stage organism corresponding organ degree of turbulence different,therefore the treatment plan regards the corresponding target organ the function condition to have the difference.Conclusion:Essential hypertension is closely related with time compliance of gene expression and induction of genes;in initial period,the medicine take to improve target organ own function,auxiliary small dosage adjustment nerve internal secretion medicine as good;to target organ already damage,adjustment nerve internal secretion medicine for essential,the association with the improvement target organ function medicine underlie,favors the target organ structure and the function restoration.
作者 丁绍祥
出处 《航空航天医学杂志》 2009年第10期30-32,共3页 Journal of Aerospace medicine
关键词 原发性高血压 发病机制 治疗 基因诱导 Essential hypertension Pthogenesis Teatment Gene-induced
  • 相关文献

参考文献11

  • 1王文,张宇清,马丽媛,刘明波,邓卿,吴海英,黄建风,刘力生,CHIEF研究协作组.CHIEF:中国高血压干预效果研究-初始低剂量钙离子拮抗剂为基础的联合方案治疗高血压的随机临床研究阶段报告-1[J].中国循证心血管医学杂志,2008,1(1):24-27. 被引量:13
  • 2陈楠,陈佳韵.ACEI和ARB的肾脏保护机制、临床研究及其应用[J].中华医学信息导报,2005,20(5):14-14. 被引量:32
  • 3刘力生,张维忠,郝建生,孙宁玲,吕卓人,王益新,王淑玉,HOT-CHINA临床研究协作组.非洛地平缓释片在高血压治疗中的达标率和安全性研究[J].中华心血管病杂志,2004,32(4):291-294. 被引量:103
  • 4Fejerman L,,Wu X,Adeyema A,et al.The effect of geneticvariation in angiotensinogen on serum levels and blood pres-sure:a comparison of Nigerians and US blacks. Journal of Human Hypertension . 2006
  • 5Dahlof B,Sever PS,Poulter NR, et al.Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-B. Lancet,The . 2005
  • 6Kakar P,,Lip GY.Towards understanding the aetiology and patho-physiology of human hypertension:where are we now?. Journal of Human Hypertension . 2006
  • 7G Bobrie,G Chatellier,N Genes.Cardiovascular prognosis of “masked hypertension” detected by blood pressure self-measurement in elderly treated hypertensive patients. The Journal of The American Medical Association . 2004
  • 8Tanira MOM,Balushi KA Al.Genetic variations related to hypertension: a review. Journal of Human Hypertension . 2005
  • 9Laurent S.Evidence for benefits of perindopril in hypertension and its complications. American Journal of Hypertension . 2005
  • 10Chlopicki S,Gryglewski RJ.Angiotensin converting enzyme (ACE) and HydroxyMethylGlutaryl-CoA (HMG-CoA) reductase inhibitors in the forefront of pharmacology of endothelium. Pharmacol Rep . 2005

二级参考文献5

  • 1Hansson L, Zanchetti A, Carruthers G, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomised trial.Lancet, 1998, 351:1755-1762.
  • 2Hansson L, Zanchetti A, for the HOT Study Group. The Hypertension Optimal Treatment Study (the HOT Study).Blood Press, 1993,2:62-68.
  • 3Guidelines Subcommittee. 1999 World Health Organization - International Society of Hypertension guidelines for the management of hypertension.J Hypertens,1999,17:151-183.
  • 4Hansson L, Zanchetti A, for the HOT Study Group. The Hypertension Optimal Treatment (HOT) Study-Patient characteristics: randomization, risk profiles, and early blood pressure results. Blood Press, 1994,3:322-327.
  • 5王文,马丽媛,张宇清,邓卿,刘明波,刘力生,代表CHIEF研究协作组.中国高血压综合干预研究方案——起始联合降压、适度调脂和生活方式综合干预的全国多中心随机对照试验[J].中国循证医学杂志,2007,7(11):810-815. 被引量:31

共引文献144

同被引文献193

引证文献22

二级引证文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部